These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 27106834)

  • 41. Pharmacological Agents Targeting Myocardial Metabolism for the Management of Chronic Stable Angina : an Update.
    Guarini G; Huqi A; Morrone D; Marzilli M
    Cardiovasc Drugs Ther; 2016 Aug; 30(4):379-391. PubMed ID: 27497930
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of aging, renal dysfunction, left ventricular systolic impairment, and weight on steady state pharmacokinetics of perhexiline.
    Ling LH; Chik W; Averbuj P; Pati PK; Sverdlov AL; Ngo DT; Morris RG; Sallustio BC; Horowitz JD
    Ther Drug Monit; 2011 Apr; 33(2):251-6. PubMed ID: 21383654
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Modulation of cardiac metabolism during myocardial ischemia.
    Chagas AC; Dourado PM; Galvão Tde F
    Curr Pharm Des; 2008; 14(25):2563-71. PubMed ID: 18991673
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Use of perhexiline maleate in angina pectoris].
    Galassi A; Mangiameli S; Circo A
    Boll Soc Ital Cardiol; 1975; 20(11):1575-9. PubMed ID: 1234455
    [No Abstract]   [Full Text] [Related]  

  • 45. Inhibition of long-chain fatty acid metabolism does not affect platelet aggregation responses.
    Willoughby SR; Chirkov YY; Kennedy JA; Murphy GA; Chirkova LP; Horowitz JD
    Eur J Pharmacol; 1998 Sep; 356(2-3):207-13. PubMed ID: 9774251
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Proceedings: Effects of perhexiline maleate in angina pectoris: a double-blind clinical evaluation with ECG-treadmill exercise testing.
    Morledge J
    Postgrad Med J; 1973 Apr; 49():Suppl 3:64-7. PubMed ID: 4587034
    [No Abstract]   [Full Text] [Related]  

  • 47. [Clinical trial by perexiline maleate in treatment of angina pectoris (author's transl)].
    Corsini G; Correale E; Oriani G; Persico S; Tritto C
    G Ital Cardiol; 1975; 5(1):73-86. PubMed ID: 1120556
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical inhibition of CYP2D6-catalysed metabolism by the antianginal agent perhexiline.
    Davies BJ; Coller JK; James HM; Gillis D; Somogyi AA; Horowitz JD; Morris RG; Sallustio BC
    Br J Clin Pharmacol; 2004 Apr; 57(4):456-63. PubMed ID: 15025744
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Warner oration. Advances in drug therapy of angina pectoris, with special reference to perhexiline maleate.
    Datey KK; Dalvi CP
    Indian Heart J; 1974 Jan; 26(1):1-5. PubMed ID: 4608031
    [No Abstract]   [Full Text] [Related]  

  • 50. Modulation of myocardial metabolism: an emerging therapeutic principle.
    Horowitz JD; Chirkov YY; Kennedy JA; Sverdlov AL
    Curr Opin Cardiol; 2010 Jul; 25(4):329-34. PubMed ID: 20535068
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Report of a multicentre monitored release study of perhexiline maleate in the prevention of angina pectoris.
    Lockhart JD; Masheter HC
    Br J Clin Pract; 1976 Sep; 30(9):172-7. PubMed ID: 826264
    [No Abstract]   [Full Text] [Related]  

  • 52. [2 new anti-angina drugs: amiodarone and perhexiline maleate. Advantages and adverse effects].
    Rullière R; Bickert P
    Rev Prat; 1976 Dec; 26(59):4251-6. PubMed ID: 1006108
    [No Abstract]   [Full Text] [Related]  

  • 53. Can Perhexiline Be Utilized Without Long-Term Toxicity? A Clinical Practice Audit.
    Phuong H; Choi BY; Chong CR; Raman B; Horowitz JD
    Ther Drug Monit; 2016 Feb; 38(1):73-8. PubMed ID: 26309031
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Perhexiline maleate in angina pectoris.
    Datey KK; Bhagat SJ; Iyer RS; Surana MC; Bhootra RK; Rajalaxmi BN; Mishra SJ; Goyal BK
    Indian J Chest Dis Allied Sci; 1976 Oct; 18(4):213-20. PubMed ID: 1032608
    [No Abstract]   [Full Text] [Related]  

  • 55. [Perhexiline maleate in the treatment of angina pectoris].
    Forattini C; Perin S
    Minerva Cardioangiol; 1976 Apr; 24(4):308-15. PubMed ID: 792717
    [No Abstract]   [Full Text] [Related]  

  • 56. [Clinical study of a new anti-angina agent: perhexiline maleate].
    Linquette M; Mesmacque R; Benoit G
    Lille Med; 1973 Dec; 18(10 Suppl 5):suppl 5:1313-5. PubMed ID: 4802930
    [No Abstract]   [Full Text] [Related]  

  • 57. [Multicentric study with perhexiline maleate in angina pectoris. Preliminary report].
    Nogueira A; Bozza A; Britto AH; Santos DV; Piero EF; Gomes FJ; Brito FS; Laffront G; Dohmann HF; Arroyo JB
    Arq Bras Cardiol; 1976 Dec; 29(6):509-20. PubMed ID: 798573
    [No Abstract]   [Full Text] [Related]  

  • 58. [Effects of perhexiline maleate in angina pectoris: preliminary clinical and experimental results of a comparative study].
    Caponnetto S; Iannetti M; Pastorini C; Masperone MA; Perugini P
    Boll Soc Ital Cardiol; 1975; 20(11):1433-7. PubMed ID: 791305
    [No Abstract]   [Full Text] [Related]  

  • 59. A new approach to the evaluation of anti-anginal drugs (with special reference to Perhexiline maleate).
    Datey KK; Dalvi CP
    Indian Heart J; 1973 Jan; 25(1):3-8. PubMed ID: 4576303
    [No Abstract]   [Full Text] [Related]  

  • 60. Effects of perhexiline maleate on coronary flow distribution in the ischemic canine myocardium.
    Klassen GA; Sestier F; L'Abbate A; Mildenberger RR; Zborowska-Sluis DT
    Circulation; 1976 Jul; 54(1):14-20. PubMed ID: 1277417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.